Combination therapies that enhance the efficacy of SMs are those that typically increase the local concentration of inflammatory cytokines, which can then be harnessed and potentiated by SMs via their capacity to sensitise tumour cells to TNF-mediated apoptosis. The gene discussed is TNF; the disease is neoplasm.